SEQSTER
SEQSTER is a healthcare data operating system that aggregates fragmented clinical, genomic, and patient-generated data into longitudinal, AI-ready records for pharmaceutical sponsors, CROs, and digital health companies across clinical trials and real-world evidence workflows.
- Company typePrivate
- Founded2016
- HeadquartersSan Diego, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What SEQSTER does
SEQSTER is a patient-centric healthcare data operating system founded in 2016 and headquartered in San Diego, California. The company aggregates fragmented clinical, genomic, and patient-generated health data into longitudinal, AI-ready records through its five-product 1-Click platform: 1-Click Patient (patient-mediated EHR retrieval), 1-Click Records (automated EHR retrieval at enterprise scale), 1-Click DataLake (population discovery across 150M+ de-identified patients and 200,000+ clinicians), 1-Click Eligibility (AI-powered clinical trial patient screening), and 1-Click Sites (turnkey clinical site enablement). Supporting modules include 1-Click Data Refinery (CCDA/FHIR harmonization into AI-ready records) and CoRD (Connected Research & Development). The platform integrates with 20+ EHR systems using FHIR and CCDA standards, maintains FDA 21 CFR Part 11 compliance, HIPAA certification with AES-256 encryption, GDPR compliance, and TEFCA Individual Access Services provider status.
The company serves three primary customer segments: pharmaceutical and biotech sponsors (Novartis, Boehringer Ingelheim, Takeda, AbbVie, Eli Lilly, Genentech, Praxis Precision Medicines) using the platform across clinical operations, medical affairs, REMS, real-world evidence, and HEOR; contract research organizations including Syneos Health and UBC; and digital health platforms (Medable, Datavant, PatientsLikeMe). Revenue is generated through quote-based annual enterprise SaaS subscriptions with custom pricing based on customer scale and use case complexity. Go-to-market is exclusively direct enterprise field sales, with a Request a Demo conversion motion on the website and active presence at major life sciences conferences including BIO International, ISPOR, JPM Healthcare, and SCOPE. The company has raised $16 million in total funding since founding, operates with 101-250 employees, and is privately held under the legal entity Seqster PDM, Inc., incorporated in Delaware.
SEQSTER firmographics
Firmographics- Name
- SEQSTER
- Legal name
- Seqster PDM, Inc.
- Website
- https://seqster.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- SEQSTER is a healthcare data operating system that aggregates fragmented clinical, genomic, and patient-generated data into longitudinal, AI-ready records for pharmaceutical sponsors, CROs, and digital health companies across clinical trials and real-world evidence workflows.
- Ownership category
- akta.pro rank
SEQSTER industry classification
Industry- Product category
- Clinical Data Interoperability Platform
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Record Locator Services (RLS) & Longitudinal Record Aggregation (HLACABAH), Clinical & Claims Data Integration for Population Health (payer-provider data fusion) (HLACAHAI)
Keywords
Where SEQSTER is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SEQSTER business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform/SaaS Licensing: SEQSTER generates revenue through licensing its patient-centric operating system platform to pharmaceutical companies, CROs, and healthcare organizations. The platform supports the full drug development lifecycle from clinical operations to medical affairs, REMS and patient services, and real-world evidence and HEOR. Revenue appears to come from subscription-based enterprise agreements with life sciences customers.
- Data Access and Query Services: Revenue generated from providing access to the 1-Click DataLake platform for cohort discovery, feasibility analysis, and real-world evidence generation. Organizations pay for access to query longitudinal patient data across the 150M+ patient network for clinical trial design and recruitment purposes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise pricing - custom quote-based model for pharmaceutical sponsors, CROs, and healthcare organizations |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
SEQSTER product offering
Product offeringCore offering
SEQSTER provides a patient-centric operating system that connects, cleanses, and transforms longitudinal health data for life sciences and healthcare stakeholders. The platform aggregates clinical, genomic, and patient-generated data from over 20 EHR systems into unified records spanning 150M+ de-identified patients and 200,000+ clinicians. Its five core '1-Click' modules (Patient, Records, DataLake, Eligibility, Sites) plus the 1-Click Data Refinery harmonization engine and CoRD research platform are sold to pharmaceutical sponsors, CROs, and digital health companies to accelerate clinical trial recruitment, automate medical record retrieval, enable real-world evidence generation, and support AI-driven clinical research.
Product overview
SEQSTER is a patient-centric operating system and data connection, collection, and orchestration layer for patient health data. The platform connects, cleanses, and transforms longitudinal health data for stakeholders in life sciences and healthcare. The product portfolio consists of five core "1-Click" modules (Patient, Records, DataLake, Eligibility, and Sites) that work together as an integrated system: 1-Click Patient enables patient-mediated EHR retrieval, 1-Click Records provides automated EHR retrieval at enterprise scale, 1-Click DataLake enables population discovery and real-world evidence generation, 1-Click Eligibility powers AI-driven clinical trial patient screening, and 1-Click Sites transforms clinical sites into research-ready data collection points. Supporting modules include 1-Click Data Refinery for data harmonization and CoRD for connected research and development. The platform aggregates clinical, genomic, and patient-generated data in real time to create a complete longitudinal view of patient health.
Differentiator
Problem solved
Functional benefit
Brands
- 1-Click Patient™: Patient-mediated EHR retrieval platform enabling patients to connect, collect and share data from any healthcare provider nationwide.
- 1-Click Records™
- 1-Click DataLake™
- 1-Click Eligibility™
- 1-Click Sites™
Products and services
- 1-Click Patient™ Patient-mediated EHR retrieval solution enabling patients to connect, collect, and share their health data from any healthcare provider nationwide through credential-based authentication with continuous updates as new clinical data becomes available. Designed for life sciences sponsors and healthcare organizations seeking patient-driven data access.
- 1-Click Records™ Automated EHR retrieval platform connecting all health records nationwide with comprehensive longitudinal health data access, advanced cohort filtering, interactive visualization of patient journeys, and FDA 21 CFR Part 11 compliant workflows. Built for enterprise life sciences, healthcare, and research customers.
- 1-Click DataLake™ Population discovery and real-world evidence platform providing access to 150+ million de-identified patients with longitudinal health records, structured and unstructured clinical data, NPI data with national coverage, and AI-ready datasets for advanced analytics. Targets pharma sponsors, CROs, and researchers needing cohort discovery and feasibility analysis.
- 1-Click Eligibility™ AI-powered patient screening solution for clinical trials that identifies and prioritizes eligible participants in minutes using AI trained on high-quality longitudinal health data, with eligibility scoring based on data completeness, recency, and fit. Built for clinical operations teams running patient recruitment for pharmaceutical trials.
- 1-Click Sites™ Platform transforming clinical sites into research-ready data collection points with turnkey activation, no software installation or custom EHR integrations required, branded FDA 21 CFR Part 11-compliant study portals, and continuous data capture across the study lifecycle. Designed for sponsors, CROs, and site networks running decentralized clinical trials.
- 1-Click Data Refinery™ Enterprise-grade data harmonization engine that transforms raw, patient-consented EHR data in CCDA and FHIR formats into clean, structured, AI-ready patient records by normalizing and deduplicating records across health systems and clinical notes. Targets pharma sponsors and CROs deploying AI in regulated clinical environments.
- CoRD™ (Connected Research & Development) Platform accelerating drug discovery and deep insights for pharmaceutical companies by connecting patient data with research workflows to enable faster development and real-world evidence generation. Built for pharmaceutical R&D organizations.
Quantifiable outcome
- Nearly 6 months acceleration in trial timelines achieved by screening 10,000+ patients and identifying eligible participants in under an hour
- +4 more outcomes
Companies that use SEQSTER
Customer profileNamed customers14 records
Segments4 records
Ideal customer profiles4 records
SEQSTER technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability8 records
Feature6 records
SEQSTER partnerships and signals
Strategic signalPartnerships
25 partnerships are on record, tiered core and flagship.
- ClairyoncoreStrategic partnership to improve sepsis detection by combining SEQSTER's real-time patient data platform with Clairyon's COMPOSER predictive AI model. Building on Clairyon's proven 17% relative reduction in sepsis mortality at UC San Diego Health, the partnership aims to scale nationally and potentially save an additional 50,000 lives by detecting sepsis earlier through real-time data access and predictive AI.
- Multiple Sclerosis Association of America (MSAA)coreTechnology partnership supporting MSIN (Multiple Sclerosis Implementation Network), a practice-based research network connecting MS care centers throughout the United States. SEQSTER enables data sharing and insights to improve care and outcomes for people living with multiple sclerosis, with the initiative expanding to over 1,000 participants across 20 sites nationwide.
- AstutecoreStrategic partnership to help healthcare organizations access patient data across clinical settings as home healthcare and remote patient monitoring efforts expand. The partnership combines SEQSTER's unified data layer with Astute's secure infrastructure to ensure continuous data availability across care settings, enabling remote patient monitoring, care coordination, and AI-driven insights.
- BioIVTflagshipBioIVT, the leading provider of human biological products for drug discovery and development, is the first deployment partner for SEQSTER's 1-Click Sites platform. BioIVT will use the platform across its clinical sample collection network to provide richer longitudinal data for drug development decisions, enabling better tracking of lab results and clinical outcomes before and after treatment.
- Praxis Precision MedicinescoreExpanded multi-study collaboration to accelerate clinical trials, data collection, and real-world evidence generation across Praxis's clinical development programs for CNS disorders. Building on early success in Praxis's Essential3 Program for Essential Tremor, SEQSTER supports the broader ENERGY program advancing vormatrigine for epilepsy treatment, supporting approximately 5,000+ patients.
- icometrixcoreStrategic partnership combining SEQSTER's 1-Click Records with icometrix's AI-powered brain imaging technology (icobrain) to enhance detection, tracking, and management of neurological conditions including Alzheimer's Disease, Multiple Sclerosis, and Traumatic Brain Injury. The integration enables healthcare providers to track disease progression with greater precision.
- PatientsLikeMecoreStrategic partnership to power PatientsLikeMe's Connected Patient Health Hub with real-time EHR data. SEQSTER serves as the EHR provider enabling rapid and accurate patient screening for clinical trial opportunities while PatientsLikeMe provides patient engagement and health tracking platforms for condition-specific communities.
- Boston UniversitycoreResearch partnership with Dr. Rhoda Au's team at Boston University Chobanian & Avedisian School of Medicine to develop an early-stage clinical screening tool for Alzheimer's disease using SEQSTER's 1-Click Records for longitudinal health data aggregation.
- AntidotecorePartnership to enhance patient identification and improve trial timelines and enrollment outcomes by leveraging SEQSTER's Operating System with Antidote's precision recruitment capabilities and best-in-class screening services.
- ThreadcorePartnership to fast-track real world data collection for patients and researchers by combining SEQSTER's data unification capabilities with Thread's clinical trial platform.
- Audacity HealthcorePartnership to accelerate clinical trial recruitment for pharma sponsors by combining SEQSTER's patient data platform with Audacity Health's recruitment expertise.
- Atropos HealthcorePartnership to accelerate patient registries in clinical research, enabling health systems to save millions and accelerate evidence generation through integrated real-world data capabilities.
- TakedacorePartnership enabling Takeda to extend its external data and digital collaboration ecosystem with better access to real-world evidence, integrating real-time data into workflows to generate powerful insights for research and patient services across 12 distinct use cases.
- Boehringer IngelheimcorePartnership to close the Real World Evidence (RWE) gap through patient-centric data access with full consent and control. SEQSTER provides a ready-to-go solution delivering high fidelity and high quality data for Boehringer Ingelheim's evidence generation needs.
- NovartiscorePharmaceutical partner utilizing SEQSTER's platform for clinical operations and real-world evidence generation across drug development programs.
- GenentechcorePharmaceutical partner participating in the Multiple Sclerosis Implementation Network (MSIN) research collaboration with SEQSTER and MSAA.
- Syneos HealthcorePartnership where SEQSTER enables Syneos to access and utilize real-world data across clinical and commercial solutions. By automating the retrieval of longitudinal patient records, SEQSTER helps reduce administrative burden at investigative sites while supporting faster, more efficient patient identification and screening.
- UBC (United BioSource)corePartnership integrating SEQSTER Admin Portal into UBC's pre-screening workflow to expedite acquisition of medical records, crucial for determining trial eligibility and capturing baseline eCRF data, enabling modernized study designs.
- MedablecorePartnership integrating SEQSTER with Medable's decentralized clinical trial platform to provide clinicians with a more holistic view of patient health, leading to higher-quality trial results while simplifying the patient experience.
- DatavantcorePartnership enabling integration of real-world data into clinical trials to accelerate the clinical and commercial development process. SEQSTER's solution utilizes patient data captured in EHRs to fill important data gaps for sponsors working with Datavant.
- Scripps Research Translational InstitutecoreResearch partnership to study the impact of health data access on healthcare decisions, combining SEQSTER's data aggregation capabilities with Scripps' translational research expertise.
- AbbViecorePharmaceutical partner utilizing SEQSTER's platform for clinical data solutions.
- Eli LillycorePharmaceutical partner utilizing SEQSTER's platform for clinical data solutions.
- Thermo Fisher ScientificcoreLife sciences partner utilizing SEQSTER's platform for data integration and clinical research support.
- Centers for Medicare and Medicaid ServicescoreGovernment health agency partner supporting SEQSTER's health data interoperability initiatives and TEFCA (Trusted Exchange Framework and Common Agreement) compliance.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
SEQSTER competitors and assessment
Company assessmentDirect peers
- Datavant: Healthcare data connectivity platform that links de-identified patient records across providers for clinical trials and real-world evidence. Directly overlaps with SEQSTER's 1-Click DataLake, 1-Click Records, and Data Refinery offerings, and is an active partner-ecosystem peer (founder Travis May publicly endorses SEQSTER).
- HealthVerity: Real-world data infrastructure and identity-resolution platform serving pharma, payers, and providers. Direct competitor to SEQSTER in patient-level data linkage, consent management, and HIPAA-compliant data exchange for clinical research.
- Medable: Decentralized clinical trial platform partnering with SEQSTER for patient-mediated EHR data. Both companies target pharma/CRO trial digitization, with Medable focused on eCOA/telehealth and SEQSTER providing the longitudinal data layer underneath.
- Atropos Health: Real-world evidence and clinical informatics platform producing on-demand evidence from EHR data. Active SEQSTER integration partner for accelerating patient registries, and a direct competitor for pharma RWE budget.
- Antidote: Clinical trial recruitment and patient-matching platform. Active SEQSTER integration partner combining Antidote's screening capabilities with SEQSTER's longitudinal data, while also competing for the same trial-recruitment budget.
Broad incumbents
- Flatiron Health: Oncology-focused EHR data abstraction and real-world evidence platform owned by Roche. Competes with SEQSTER in oncology RWE and clinical-trial EHR aggregation, with deeper specialty focus but narrower therapeutic coverage than SEQSTER's horizontal platform.
- IQVIA: Global clinical research services and real-world evidence leader. Overlaps with SEQSTER across CRO, RWE, and trial-recruitment services for pharma, but operates at vastly greater scale and breadth as a diversified incumbent.
- Veradigm (formerly Allscripts): Major EHR and clinical data platform serving ambulatory providers. Competes with SEQSTER as an incumbent data source for life-sciences research via its FollowMyHealth and Research offerings, while also being a potential integration partner.
Emerging players
- Tempus: AI-powered precision medicine platform combining clinical and molecular data for oncology. Overlaps with SEQSTER on AI-ready longitudinal patient records and pharma-grade datasets, though with a deeper genomics focus and broader therapeutic ambition.
- Clinerion: International patient-data network for clinical trial feasibility and real-world evidence across hospital systems. Comparable to SEQSTER's 1-Click DataLake but with broader European hospital coverage, serving as an indirect peer for global pharma sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
SEQSTER social profiles
Digital presenceSEQSTER compliance and trust
Trust signalCompliance3 records
SEQSTER financial estimates
Financial estimateRevenue estimate
Valuation estimate
SEQSTER leadership team
Management profileNumber of profiles
Profiles2 records
SEQSTER funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SEQSTER M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SEQSTER
What does SEQSTER do?
SEQSTER provides a patient-centric operating system that connects, cleanses, and transforms longitudinal health data for life sciences and healthcare stakeholders. The platform aggregates clinical, genomic, and patient-generated data from over 20 EHR systems into unified records spanning 150M+ de-identified patients and 200,000+ clinicians. Its five core '1-Click' modules (Patient, Records, DataLake, Eligibility, Sites) plus the 1-Click Data Refinery harmonization engine and CoRD research platform are sold to pharmaceutical sponsors, CROs, and digital health companies to accelerate clinical trial recruitment, automate medical record retrieval, enable real-world evidence generation, and support AI-driven clinical research.
Is SEQSTER a public or private company?
SEQSTER is a private company. It is classified as venture growth investor backed and is currently operating.
When was SEQSTER founded?
SEQSTER was founded in 2016. It employs 101 to 250 people.
Where is SEQSTER based?
SEQSTER is headquartered in San Diego, United States, in the North America region.
How does SEQSTER make money?
Two revenue lines are on record. Platform/SaaS Licensing is the primary driver. The others are data Access and Query Services.
Who are SEQSTER's main competitors?
Direct peers on record are Datavant, HealthVerity, Medable, Atropos Health and Antidote. Broad incumbents are Flatiron Health, IQVIA and Veradigm (formerly Allscripts). Emerging players are Tempus and Clinerion.
Does SEQSTER have an API?
No public API is recorded for SEQSTER.
What industry is SEQSTER in?
SEQSTER's product category is Clinical Data Interoperability Platform. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACABAH, Record Locator Services (RLS) & Longitudinal Record Aggregation. Its NAICS code is 518210 and its SIC code is 7372.